This study used the guinea pig keratoconjunctivitis model to examine the importance of route of administration (mucosal versus parenteral), frequency and timing of immunization (primary versus boosting immunization), and form of antigen given(live attenuated vaccine strain vcrsus 0-antigen-protein conjugate) on the production or protective immunity against Shigella infection. Since local immune response to the lipopolysaccharide (LPS) O-antigen of Shigella ssp. is thought to be important for protection against disease, 0-antigen-specific antibody-secreting cells (ASC) in the spleen and regional lymph nodes of immunized animals were measured using an ELISPOT assay. Results indicated that protective efficacy was associated with a strong O-antigen-specific ASC response, particularly in the superficial ventral cervical lymph nodes draining the conjunctivae.
ABSTRACT (Maximum 200 words)
This study used the guinea pig keratoconjunctivitis model to examine the importance of route of administration (mucosal versus parenteral), frequency and timing of immunization (primary versus boosting immunization), and form of antigen given(live attenuated vaccine strain vcrsus 0-antigen-protein conjugate) on the production or protective immunity against Shigella infection. Since local immune response to the lipopolysaccharide (LPS) O-antigen of Shigella ssp. is thought to be important for protection against disease, 0-antigen-specific antibody-secreting cells (ASC) in the spleen and regional lymph nodes of immunized animals were measured using an ELISPOT assay. Results indicated that protective efficacy was associated with a strong O-antigen-specific ASC response, particularly in the superficial ventral cervical lymph nodes draining the conjunctivae.
In naive animals, a strong ASC response in the cervical lymph nodes and protection against challenge were detected only in animals that received a mucosal immunization.
Protection in these animals was increased by a boosting mucosal immunization. While parenteral immunization in alone with an O-antigen-protein conjugate vaccine did not protect naive animals against challenge, a combined parenteral-mucosal regimen elicited enhance protection without the addition of a boosting immunization.
Although O-antigen-specific serum im unoglobulin A titers were signif c ntl biher i? animals recegving a mucosal immunizatiin, tfere was no apnarent correlat on ewtwee levels o serum antibo y and protec ion against NA. SUBJECT TERMS disease. 17. 26t), and there is also evidence that the presence of serumn tion). and formi of antigeni giveni (live attenuated \accine strain antihodies against the lipopolvsaccharide (1.1S) 0-antigenl are versus 0-anltilgenl-protein1 ConjUgate ) Onl thle iiidUetioll of proassocia ted with protect ion against dlisease ( 2. 3. 5 ). Thus, the teetiye inminruitii ty against disease in ii aix aniniia Is anid to LITS 0-ant igen ii ay hc at critical antigen in the development of examin fiilt e relationship of' lie secrtn Mi id local1 i in inn neC proitective inmmunity against disease.
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responses geiierated liv immuni tiiatin nit protect iton. II lol mgrell Local immunity is thought to play an import anit role iii el alI. ( 19) pro po sed that de term inat iton of ilie aiit iht id redefense against bacterial e nte ropat hti)geus like sh igellIae that spouse agaitnst p)rotective a ut igcw sl attlie lin uctisaIl sitec of, infect mucosal surfices ( 19. 2(0). After earlier studies dICmou0-anlrigri stimulation may represent at More aIccurate represenstrafed that parenieral imniul~nization with live or-killed sie-tattil (of, tile loctal invin inc u eesp( n se i hit tile inca su remlent iof lac did not protect against infection ( 11 1 I8. 37). recent efforts anltihodies in hodx' ffluids ixxhere degraidationi and hialf-life of' have emphasized the development tif' orally administered anltiblody molecules inluenLce1C the a1ccuracy of' analyses. Meaattenuated vaccine strains to indue nilucosid immunlllitV to sriletoaitti-srtigmp .S'hiella antigens (9. 10I. 21, [24] [25] [26] [27] The S. fl'xncri 2a polvsaccliarideC-prOteiii COn~jugaIc VaCCuiie wa&S was iadministered by a lniucosal route. i.e.. oculaIr inoculation, administered twice subcutaneously (protocol I P-13-SC). Three by using a priniary inimuniizationi only, its in protocol M. orcombination regimens were testedl (protocols I PM-SC. I PMprimary and boosting Immnunizaitions. ats iii protocol M-13. A B-S('. aiid MI P-SC). Ii MI IP-SC'. the plimnar\ dose wats givenl polysacceharide-protcin conjigaIte vaccine consisting of' S. fle '-rnucosallv, aiid the boosting (lose wais given sUbeitane11OUSly. A ite'ri 2a 0-antigen COiiju'aited toP' aeru5'tilo.va exoproteinl A (3, regimen usin primary anid boosig( 1IOilLOC f cti-34. 35) wats administered intrapeiritonecally ( i.p. I by using
[protocol M-13(a)j Wats alSO incl~uded inl this experimental aluminum hydroxide ats thle adjuvant. either in at single dlose group. (protocol II') or with two boosting doses (protocol 113-1). Two
Immunization of' animals. Ocular imn~lUIiuniza ons \%[s ere0don combiniation parentetral-mu1.cosal regimens were tested (protoas, describe(] previously ( 16). In thle ease ofl the live EcSf'2a-2 coils IPM and IPM-13, which included at boosting dlose of' vaccine. bacteria were reconstitutedl as described] in "Bacterial FcSf2a-2). Nonininiunlized aninials were used to deternmine strains anid vaccines" above, and~ 0.105 mil was inoculatedl into background readings (protocol NC') and as conitrols in proteceach eye of the animials. For each immunization. the inloculumn tion experiments. Inmmriniz~ation with an Unrelated polysacchawas determlinel by hcolonyCU~1 Oou il t 17n 1 Pt iCaIs So\,gi plaltes: ride conjugate (protocol I PC'). !'ncitnococcu~s ty'pe 6A polysacthe average dlose \%ias 2 x I10' to 4 x I16.1 Clii per eve. F-or i~p.
ch aridLe conjugatted to tet anuis toxo id, wats used its a con t rol to administ rathion of' tilie pm dysaceli aride-prot e in conijuLgate \iac-ensure that nonspecific immunity inducedl by adniinistrationr of Cinies, thle vaIc61c inews 11 h1oroUgh1lv iXed Wit tli al Cq;Ial voIlume at plilysacchuiritle conjugaite wats not responsible for proitect ion ELISA. An enzyme-linked immunosorbcnt assay was used to tion. the animals were challenged with virtulenl S. flkevri 2a quantitatc the serum antibody response toS. fle.xeri 2a LPS as strain 24571" at a dose of"4 x I10' to 5 × I 10 CFU per eve, as described previously ( 16) but with modilications to measure all determined by colony count of the inoct h ni. After challenge, isotvpes. The LPS antigen "ias diluted to a concentration of I1 the animals were examined for 7 days for development of ji.rnml in carbonate coating buffer (described above), the wells kcratoconjunctivitis. The decgree of kcratoconjunctivitis wits of polyvinyl microtiter plates (Dynat cch Laboratories. Inc.. rated on the basis of time of development and severity of Cliantilly, Va.) were coated with 50 p.1 of LPS souhtion or symptoms (I 6) 1-'everity of infection in tlie eves ot animals carbonate bulfer alone, and the plates wcrc incubated overwas rated aflter challenge by the following Itiur-point scale: 0.
night at 4(CC. After being washed, the plates were blocked with no disease or mild irritation: 1. mild keratoconjunctivitis or late casein solution for I h at 37(C. After washing the plates with development and/or rapid clearing: 2. keratoconjutnctivitis, but PBS-Tween, guinea pig sera. serially diluted twofold in) casein no ptirtilenee; 3. fully developed kcratoconjunctivitis, with buffer, were added to the wells, and the plates were incubated purulence. A rating for each animal was determined by the for 2 h at 37CC. After washing the plates. 51) [L 1 of anti-guinea highest eye rating. Protection was defined as follows: full pig IgG, IgA, or IgM ((ICN Laboratories) in the dilutions used protection, no disease or mild irritation (score of' 0): partial in the ELISPOT assay was added to each well, and the plates protection. mild keratoconjunclivilis or late development were incubated for 2 h at 37TC. After the plates were washed. and/or rapid clearing (score of I): combined protection, full or 511 Vi 1 of a 1:1,200 dilution in casein of goat anti-rabbit IgG partial protection (score of 0 or I ).
Conjugated to alkaline phosphatase (Sigma Iaboratories) was Preparation of cells for ELISPOT assay. Animals wcrc added to each well. After a 2-h incubation at 37-C. the plates sacrificcd by injection with sodium pentobarbital, and the were washed with PBS-Tween and 1001 fld Oif the substrate (it spleens, regional lymph nodes (superficial ventral cervical l-mninl concentration of p-nitrophcnyl phosphate in I M lymph nodes [SVCLNJ. mandibular nodes [MDI.NJ. and nicsdiethanoolanine buffer. [pH 9.81. containing 11.5 fnM MgCI,) enteric nodes (MSLN[). and Pcycr's patches (PP) were harwas added to each well. Optical density was read at 405 nmil. vested. After the lymph nodes were teased to release the Endpoint titers were delined as the last dilution having an lymphocytes, the cell suspension was put through a sterile optical density of 0.1 or greater above that of the background screen to remove debris and washed once with RPMI 16411 wells (carbonate bullcr only). Titers oLf sera obtained from the medium (GIBCO Laboratories, Gaithersburg. Md.) containing ainials prior to inimnization were used to determine back-15 ptg of gcntamicin (GIBCO) per ml. The erythrocytes in a ground titers: these values were <25 for IgA and IgM and <5U single-cill suspension of the spleens were lys-d with c and MDI.N) were plotted for each aniiial. Similar plots were rpg of gcntarnicin per ml at 2.5 x 10t" cells per ml.
constructed for each immunization group for ASC data oil-ELISPOT assay. The 0-antigen-specific ASC response of tained at 13 days pomstimmunization (n = 2 in each group) and the animals to immunization and challenge was determined by 7 to 8 days postinfection (n = 2 in each group). Geometric using a modihication of the ELISPOT assay based on the mean serum titers ( ± standard error) were used to summarize method of Czerkinsky et al. (7). Briefly. each Well of 96-well the serum immune response (IgG. IgA, and IgM) obtained itt microtiter plates (Nunc-immuno Maxisorb plates: Nunc. Ros-13 days postiiimunizalion (n = 4 in each vaccine group). kilde. Denmark) was coated with I pxg of S. fh'xneri 2a LPS Frequency distributions of the infection severity rankings and (prepared by the method of Wcstphal and Jann [41I) in 21 niM corresponding protection rates were used to summarize proNa_,CO, buffer (pil 9.6) or with carbonate huffer alone. After tection data from challenge experiments (n = 4 to 8 for each being washed once with PBS. the plates were ilocked with 51, group). Two-way analysis of variance (ANOVA) was used as fetal calf serum in PBS for I h and washed with PBS prior to part if' the overall data analysis stralcgy to assess the differuse. Prepared cells were dispensed at 100 il) per well, and the cinccs in outcome measures due to the effects o(f (i) route (if plates were incubated for 4 h at 37'C( in a humidified CO. administration (M. IP. IPM), (ii) boosting dose (presence or incubator. After incubation. the plates were washed four times absence), and (iii) the interaction of route and booster (33). with PBS-(l.05rr Twccn 201 (PBS-Twcen). I(1(0 .l if anti-guinea Seruti titer data wcre log (rainsfornlIcd (base 10I) in all analses. pig IgG. IgA. or IgM ('ICN Laboratories) per well wits added
In the case (if the infectiii severity ratings (ordinal data). this, (anti-guinea pig IgG, 1:1.2111) dilution in casein solution, concorresponds to the rank-transform method (6). When ovcrall sisling of 21) gi of cascin and 2.11 g of sodiutm azide in PBS per differetnces (by ANOVA) were significant (P < 01.115). specilic liter IptI 7.2 to 7.41; anti-guinca pig IgA and IgM, 1:8011 comparisons (lby ANOVA mean squarc erroir) were madc (c.g.. 
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Measurement of 0-antigen-specific ASC in the spleen and 500OhE regional lymph nodes of infected animals. To establish that tlie o 400 guinlea pig keratoeonlunetivitis model canl" be uIsed to measure 30 infeteion and1( to examine thle t 11111 n of, thIiis response. anl < 200 -1 [LISPOT assay was used to detect S. /kx~lnri 2a 0-antigen-100 specitie ASC in the spleen. 11) atid regional lrniph nodes of' gulineat pivs ocuilarly infected In'S. flex,,eii 2a strain 2457T. The 0 lyrpli nodes examined were the MDI)N MSLN. and SVCTN. 700 wh1ich drain the eve and other hlead regions. 6J g Animials were infected with strain 2ý4571. and1. 0-anltigenl-ý uG Ig specific IgGi-IgA-. and lgM-ASC' were measured in the 1150 Spleen. PP. andl regional lymiph nodes in one or two animials for each time point tor I0 to 44 days postinfeetion (Fig. 1 ) . The 2 0 spleen. PPll and tregional lymnph nodes from11 two unlinfeteCtd C-,-300 animials wecre examinied On dayV 0 for background count11s and V)
-< 200
we re ncgaitiN c lto-specific ASC. After infection. the 0-aiitigzenspecific AS( response for all three isotvpes lpcaked arlounid 12 1 00 -dlays. dropped by I15 days. and wanied I%' 37 to 44 davs0 postintection, kilcic only at few specific ASC were observed.
As showsn in I io. I. th majority oif 0-ntritigen-speci tic ASC 700 wecre located in the SVCLN and the spleen 8 to 12 days 600 - leA-,-l' and "gee ted ain t 2e 7pt1e. animials fromn each protocol group (11 2). as shiowvn inl Fig. 2 There was nit dectecta ble hoo ste r e tiect antd nit evide iice thaiit botoste r in thle lymnph tiodes d raini ng thle site o f i ninni tiia tion Ox-e. eflccts, depenided on route ( no interactioti). Iii aiiinials receix -SVCL N ) otilv if' there wkts at nitieoasl itiimiitiization. Averagec ing only parenteral imimuniizationis (il aPnid [Pl-13). few 0-AS( citunts for thie 1P1M group wkere somewhatii highert thial antitigen-specilic AS(' were detected iti the animials receivitig those foir the M groulps (MI or M-ll). and thle conibitied only one immunization (I P). while specific IgGi-ASC were reCgitletCis ([IM 1tid l1 9 M-13) hald it lairger propoirtioin of' 0-dectectd in the spleens of animials receiving three immiitinizaantigeti-specilic lgM-ASC thian aniy of' the other groups. suigtiitns (W -13). There was little 0-aiitigeii-specitic IgA-ASU gestilig eiihanced activatioti of' ailtigen-specilie \irgiti B cells. response iti atnimals froti either thie I P or I I'-I grouip, atid till Avcriigc hg( -anid IgA-ASC responses were soniewliat inspecific AS( were fouind in thle SV X 'I N. coint rast. aiiiin~ils creased whencl boosting reginillsl (NI-I and IPIM-li) weCre receiving atl least (inc ni ucostIi iii mmiuniziattionli ( M. M -BI. II1M.
A:td iii iiisle red~. lii11111i ituti o i/tii \ ith fi lie I't'Otul a pi 1lys~it-and IPM-B) had significantly (I' < 01.0011 ) higher numbecrs of' charide cotnjugatte (I PC') promduced no detectable 0-antigeti-0-atitigen-specifie AS' oif all isotypes thiati those receiving specific ASU. only pareiiteral imimunizationts, aiid specific AS('%were tfounid iti Plrotective efficacy after immunization. Foiirteenl dayxs after the S V( '1N as5 well as in thle spleens of iitese aniniia Is. These thle last i 11111litii i/il t 111. tile aliiia \%~ I e t chatlIentged a it I resultIs denmonst rate that 0.aiitigeti-spicitic AS(AI-weredetectd kvirtiletit S. fli'Xni'ri 2au st rain 2457'1. 
r~~niaii.To(three iltcas(t'hePMgroup) antimals from11
Homologous priming needed in combination regimen f'or each immilunizationi group (described inl [ahle 1) \%ere analvzed. For enhanced protective efficacy. To determine whether the primcacti animalf. positivc fg(G-. igA-. and lgM-AS(' counits tsere detering influence of the pareniterallv administered 0-antigenmined tor the SVCLIN. thle spleen, aind "other" sites (MISLN. MIDI.N.
protein con1ju~gate was the result of serotvpe-specihec stimula-1i and P11). tion. heliterologousS s (.iti -anthgen conuaewa sdi the initial parenteral immunizit ion (IPM-son). Tile protective efficacies and local immune responses were compared between studies. assessed by the rating of the severity of keratoconjunelthese animials and animials immunized by regimen 1PM b\ tivitis. are summarized in Table 2 . Statistically significant using the homologous 0-anitigenl conjugateC (Table 3) . Animials reductions in severity 1'rm that of nonvaceinated animals (NC' f'rom tile IPM-son group did not produce an AS(' response were obtained in all cases when the vaccine regimen contained comparable to that found inl the IPM animials (Table 3) . aI niucosal immunization with the EcSf2a-2 vaccinec (either M.
Although tile infection severity scores in thle heterologous M-13. IPM, or IPM-B3 compared with NC, maximum P value.
group (IPM-son) wecre significantly~ less than those of* rlonini-((.02;, Wilcoxon rank sum test). When thc parenterallv adminmunized animals (P =(1ROW Wileoxon rank SLUm test), thle%' istered S. fl'xn'ri 0-1 intigcn conjugate vaccine was given alone were significantly greater than those of the homologous group lIP) or boosted lIP-B) or when the unrelated polysaccharide (i.e.. IPM: 1P = 6.)009). The corresponding observed protection conjugate vaccine (IPC) was given, infection severitV was rates were 38'i (3 of' 8 animals) for the IPM-son group and essentially identical to that seen in nonimimunized control I100(Ic (8 (if 8 animals) t'or the IPM group. indicating that animals (NC). By using at twol-way ANOVA. the overall effect homologous priming is necessary forF 111L eoh11iCCIe prottective (if route oif administration ( M, I P. olr IPM) on protection rates efficacy observed inl thle IPM animials. wais highly significant (P < 0.000(1). Although thle overall Combined subcutaneous-mucosal immunizations produce difference between boosted and nonboosted protocols was iiot enhanced protective efficacy. To f'urther explore tlie enhanced significant (1) = ((.083). there was at significant interaction effect protective efficacy observecd inl thle combined parenteral-niuco-(P = (0.04(0) due to the booster effect seen (only in the mucosal sal immunization regimecn. additional experiments using three group (M. M-13), i.e., at boosting dose in the niucosal group combined subeutaneous-mucosal regimens (IPM-S('. IPM-B-(M-13) significantly increased protection over that of' the SC. and Ml P-SC': Table I Tables 2 and 4 show that a Primary combinecd average IgM-ASC eOu~nt. 1,200) versu~s 233). In addition, more pareinteral-mueLIosal immunization regimen using either the i.p.
than 50" of the postehallenge 0-antigen-specific ASC wecre or s.c. route for the parenteral immunization produces enlocated in the SVCLN. These results suggeLIst that this ConljUhanced protect ion aga inst challenge without the addition of' a gale vaccine suIccessfullyI primed the immune system, but since boosting immunization. The Ml P-SC' regimen. although prolocal priming at the site of' in feet ion did not occur pmrior to dueiffi Significant protection over that observed in the control challenge. the secondary response seen afler infecction was too animals, did not produce thle enhanced protection observed iii late to provide protect ion. The second highest AS(' countIs the IPM-SC group (MIP-SC, 50';, IPM-SC. 10010 . These rslsindicate the importance of* timing~ andodr(t. muILCOSal and then parenitcral or pareniteral and then mueLIosal) of' the immunizations il tlie combined regimens. ott tier sitcs, ) M StN. Ml) N. andi 11').
